Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Skin Neoplasms 2Sarcoma, Kaposi 2Sarcoma 2Melanoma 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solitary Fibrous Tumor, Pleural 1Rectal Neoplasms 1Prostatic Neoplasms 1Neoplasms, Unknown Primary 1Neoplasms, Plasma Cell 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Mesothelioma, Malignant 1Kidney Neoplasms 1Head and Neck Neoplasms 1HIV Infections 1Gastrointestinal Stromal Tumors 1Colorectal Neoplasms 1Colonic Neoplasms 1Acquired Immunodeficiency Syndrome 1AIDS-related Kaposi sarcoma 1

Interventions

Paclitaxel 2nirogacestat 1halofuginone 1etoposide phosphate 1Thalidomide 1Sunitinib 1Semaxinib 1Saquinavir 1Ritonavir 1Peripheral Blood Stem Cell Transplantation 1Nelfinavir 1Interleukin-12 Subunit p35 1Indinavir 1Imatinib Mesylate 1Ifosfamide 1Filgrastim 1Etoposide 1Cidofovir 1Carboplatin 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × AIDS-related Kaposi sarcoma × Semaxinib × Clear all
NCT00005042 2014-08-29

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

AIDS Malignancy Consortium

Phase 2 Completed
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡